Mydecine Innovations Group is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions.

Currently Mydecine Innovations Group encompasses three companies, each with its own unique vertical focus and core strengths that position it to be a market leader. Collectively these companies also act as an integrated entity that is greater than the sum of its parts, both in output and impact.

Name Mydecine
Symbol MYCO